These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 33892782

  • 1. Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report.
    Kikuchi F, Saheki T, Imachi H, Kobayashi T, Fukunaga K, Ibata T, Sato S, Ban N, Lyu J, Japar S, Murao K.
    J Med Case Rep; 2021 Apr 23; 15(1):214. PubMed ID: 33892782
    [Abstract] [Full Text] [Related]

  • 2. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
    Thapi S, Leiter A, Galsky M, Gallagher EJ.
    J Immunother Cancer; 2019 Sep 12; 7(1):248. PubMed ID: 31511065
    [Abstract] [Full Text] [Related]

  • 3. Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.
    Chang LS, Barroso-Sousa R, Tolaney SM, Hodi FS, Kaiser UB, Min L.
    Endocr Rev; 2019 Feb 01; 40(1):17-65. PubMed ID: 30184160
    [Abstract] [Full Text] [Related]

  • 4. Fulminant Type 1 Diabetes Mellitus Developed about Half a Year after Discontinuation of Immune Checkpoint Inhibitor Combination Therapy with Nivolumab and Ipilimumab: A Case Report.
    Yaura K, Sakurai K, Niitsuma S, Sato R, Takahashi K, Arihara Z.
    Tohoku J Exp Med; 2021 Aug 01; 254(4):253-256. PubMed ID: 34373422
    [Abstract] [Full Text] [Related]

  • 5. Magnetic resonance imaging criteria of immune checkpoint inhibitor-induced hypophysitis.
    Nada A, Bhat R, Cousins J.
    Curr Probl Cancer; 2021 Feb 01; 45(1):100644. PubMed ID: 32888700
    [Abstract] [Full Text] [Related]

  • 6. Nivolumab induced hypophysitis in an advanced RCC patient.
    Korkmaz Yilmaz M, Gulturk I, Tacar SY, Yilmaz M.
    J Oncol Pharm Pract; 2022 Apr 01; 28(3):759-762. PubMed ID: 35006033
    [Abstract] [Full Text] [Related]

  • 7. Nivolumab-induced type 1 diabetes mellitus as an immune-related adverse event.
    Yilmaz M.
    J Oncol Pharm Pract; 2020 Jan 01; 26(1):236-239. PubMed ID: 30955467
    [Abstract] [Full Text] [Related]

  • 8. Painless Thyroiditis and Fulminant Type 1 Diabetes Mellitus in a Patient Treated with an Immune Checkpoint Inhibitor, Nivolumab.
    Sakurai K, Niitsuma S, Sato R, Takahashi K, Arihara Z.
    Tohoku J Exp Med; 2018 Jan 01; 244(1):33-40. PubMed ID: 29343652
    [Abstract] [Full Text] [Related]

  • 9. [A Case of Metachronous Occurrence of Interstitial Pneumonitis and Hypophysitis Following Nivolumab Plus Ipilimumab for Metastatic Renal Cell Carcinoma].
    Hayase T, Washino S, Mayumi S, Yazaki K, Nakamura Y, Oshima M, Konishi T, Saito K, Miyagawa T.
    Hinyokika Kiyo; 2021 Jun 01; 67(6):239-243. PubMed ID: 34265899
    [Abstract] [Full Text] [Related]

  • 10. Autoimmune hypophysitis secondary to therapy with immune checkpoint inhibitors: Four cases describing the clinical heterogeneity of central endocrine dysfunction.
    Hartmann A, Paparoupa M, Volkmer BG, Rompel R, Wittig A, Schuppert F.
    J Oncol Pharm Pract; 2020 Oct 01; 26(7):1774-1779. PubMed ID: 32164491
    [Abstract] [Full Text] [Related]

  • 11. Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation.
    Sekizaki T, Kameda H, Oba C, Yong Cho K, Nakamura A, Miyoshi H, Osawa T, Shinohara N, Atsumi T.
    Endocr J; 2019 Oct 28; 66(10):937-941. PubMed ID: 31217401
    [Abstract] [Full Text] [Related]

  • 12. [Endocrine side effects of checkpoint inhibitors].
    Chen WJY, Krul-Poel YHM, Roth C, Labots M, van den Eertwegh AJM, Dreijerink KMA.
    Ned Tijdschr Geneeskd; 2019 Oct 31; 163():. PubMed ID: 31714042
    [Abstract] [Full Text] [Related]

  • 13. Nivolumab-induced Hypophysitis, Secondary Adrenal Insufficiency and Destructive Thyroiditis in a Patient with Lung Adenocarcinoma.
    Mishima Y, Fukaishi T, Inase N, Isogai S.
    Intern Med; 2019 Mar 01; 58(5):693-697. PubMed ID: 30449786
    [Abstract] [Full Text] [Related]

  • 14. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
    Godwin JL, Jaggi S, Sirisena I, Sharda P, Rao AD, Mehra R, Veloski C.
    J Immunother Cancer; 2017 Mar 01; 5():40. PubMed ID: 28515940
    [Abstract] [Full Text] [Related]

  • 15. Nivolumab-induced diabetes mellitus-a case report with literature review of the treatment options.
    Daetwyler E, Zippelius A, Danioth S, Donath MY, Gut L.
    Front Immunol; 2023 Mar 01; 14():1248919. PubMed ID: 37965350
    [Abstract] [Full Text] [Related]

  • 16. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N, Kobayashi M, Ohashi K, Ito R, Ikeda Y, Kawaguchi G, Yoneoka Y, Hasegawa G, Takada T.
    J Med Case Rep; 2019 Mar 26; 13(1):88. PubMed ID: 30909965
    [Abstract] [Full Text] [Related]

  • 17. Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report.
    Kopecký J, Kubeček O, Geryk T, Slováčková B, Hoffmann P, Žiaran M, Priester P.
    J Med Case Rep; 2018 Sep 15; 12(1):262. PubMed ID: 30217214
    [Abstract] [Full Text] [Related]

  • 18. Management of toxicities of immune checkpoint inhibitors.
    Spain L, Diem S, Larkin J.
    Cancer Treat Rev; 2016 Mar 15; 44():51-60. PubMed ID: 26874776
    [Abstract] [Full Text] [Related]

  • 19. Nivolumab Induced Adrenal Insufficiency: Rare Side-effect of a New Anti-cancer Therapy - Immune-checkpoint Inhibitors.
    Rai M, Go M.
    Cureus; 2020 Apr 10; 12(4):e7625. PubMed ID: 32399358
    [Abstract] [Full Text] [Related]

  • 20. Association between immune-related adverse events and prognosis in patients with metastatic renal cell carcinoma treated with nivolumab.
    Ishihara H, Takagi T, Kondo T, Homma C, Tachibana H, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Okumi M, Ishida H, Tanabe K.
    Urol Oncol; 2019 Jun 10; 37(6):355.e21-355.e29. PubMed ID: 30935847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.